-
(单词翻译:双击或拖选)
Britain administered the world's first fully1 tested and approved COVID-19 vaccine2 to citizen Margaret Keenan on Tuesday.
"I feel so privileged to be the first person vaccinated4 against COVID-19," said Keenan, who turns 91 next week. "It's the best early birthday present I could wish for because it means I can finally look forward to spending time with my family and friends in the New Year after being on my own for most of the year."
Prime Minister Boris Johnson called the first injection "a shot in the arm for an entire nation" as British officials prepared to vaccinate3 400,000 more people.
American drug-maker Pfizer and Germany's BioNTech developed the vaccine. Britain is first providing the vaccine to healthcare workers and people over age 80 in hospitals or under other immediate5 medical treatment.
Last week, Britain became the first country to approve the vaccine for emergency use.
U.S. confirms vaccine safety and efficacy
In the U.S., the Food and Drug Administration (FDA) released a document Tuesday confirming that the Pfizer-BioNTech vaccine was strongly effective against COVID-19.
The FDA released the documents as it prepares to rule on Pfizer's emergency use request of the vaccine this Thursday.
Pfizer and BioNTech reported that its treatment appeared to be 95 percent effective against COVID-19 in a large study of 44,000 volunteers. They said only eight volunteers who had received the two-shot treatment were among the 170 confirmed cases of COVID-19.
The FDA report says the Pfizer-BioNTech vaccine was 52 percent effective against COVID-19 after one shot. The efficacy rate rose to 95 percent after volunteers were given the second shot three weeks later.
The agency added that the test vaccinations7 raised "no specific safety concerns" linked to age, race, ethnicity, weight or medical conditions of recipients8. Many volunteers in the study reported minor9 side effects, including tiredness and moderate pain, after the shots.
The study, however, did not include people under the age of 16 or pregnant women. It also does not provide an answer on how long the shots would protect people after vaccination6.
The FDA's vaccine advisory10 committee is to meet Thursday for a public discussion of Pfizer's emergency use request. On December 17, the committee plans to examine findings of another COVID-19 vaccine trial from American drug-maker Moderna.
Both vaccines11 from Pfizer and Moderna are made with a technology called messenger RNA, or mRNA. They do not contain an inactive or weakened virus like traditional vaccines.
To make an mRNA vaccine, scientists create a genetic12 material that directs the human body to produce antibodies that can recognize and destroy the new coronavirus.
Other vaccine news
The Oxford-AstraZeneca partnership13 also published COVID-19 vaccine trial results Tuesday. The findings appeared in the British medical publication, The Lancet.
The trial found the treatment was 62 percent effective among volunteers given two full doses of the vaccine. Among those who received a half-dose followed by a full dose, the vaccine was 90 percent effective against the disease.
The study said, "(This) will require further research as more data becomes available from the trial."
The Oxford-AstraZeneca vaccine is less costly14 to produce and easier to transport than the mRNA-based vaccines. Based on agreements with the U.S. government, vaccines from Moderna and Pfizer will cost between $15 and $25 a treatment. Oxford-AstraZeneca's vaccine will cost under four dollars.
On Saturday, Russia began vaccinating15 thousands of doctors, teachers and others with its Sputnik V vaccine. China has also begun a vaccination campaign. The country is also selling its vaccine to other nations, including Turkey, Brazil and Indonesia.
The Russian and Chinese vaccines did not complete full medical trials that scientists consider necessary for safe and effective use.
Words in This Story
privileged - adj. having special rights or advantages that most do not have
specific - adj. clearly or exactly presented or stated
dose - n. the amount of medicine that is given or taken at one time
1 fully | |
adv.完全地,全部地,彻底地;充分地 | |
参考例句: |
|
|
2 vaccine | |
n.牛痘苗,疫苗;adj.牛痘的,疫苗的 | |
参考例句: |
|
|
3 vaccinate | |
vt.给…接种疫苗;种牛痘 | |
参考例句: |
|
|
4 vaccinated | |
[医]已接种的,种痘的,接种过疫菌的 | |
参考例句: |
|
|
5 immediate | |
adj.立即的;直接的,最接近的;紧靠的 | |
参考例句: |
|
|
6 vaccination | |
n.接种疫苗,种痘 | |
参考例句: |
|
|
7 vaccinations | |
n.种痘,接种( vaccination的名词复数 );牛痘疤 | |
参考例句: |
|
|
8 recipients | |
adj.接受的;受领的;容纳的;愿意接受的n.收件人;接受者;受领者;接受器 | |
参考例句: |
|
|
9 minor | |
adj.较小(少)的,较次要的;n.辅修学科;vi.辅修 | |
参考例句: |
|
|
10 advisory | |
adj.劝告的,忠告的,顾问的,提供咨询 | |
参考例句: |
|
|
11 vaccines | |
疫苗,痘苗( vaccine的名词复数 ) | |
参考例句: |
|
|
12 genetic | |
adj.遗传的,遗传学的 | |
参考例句: |
|
|
13 partnership | |
n.合作关系,伙伴关系 | |
参考例句: |
|
|
14 costly | |
adj.昂贵的,价值高的,豪华的 | |
参考例句: |
|
|
15 vaccinating | |
给…接种疫苗( vaccinate的现在分词 ); 注射疫苗,接种疫苗 | |
参考例句: |
|
|